You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Vascular‐endothelial‐growth‐factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancer
|
|---|---|
| Published in |
Cochrane database of systematic reviews, July 2012
|
| DOI | 10.1002/14651858.cd008941.pub2 |
| Pubmed ID | |
| Authors |
Anna Dorothea Wagner, Christoph Thomssen, Johannes Haerting, Susanne Unverzagt |
| Abstract |
Vascular-endothelial-growth-factor (VEGF) is a key mediator of angiogenesis. VEGF-targeting therapies have shown significant benefits and been successfully integrated in routine clinical practice for other types of cancer, such as metastatic colorectal cancer. By contrast, individual trial results in metastatic breast cancer (MBC) are highly variable and their value is controversial. |
X Demographics
The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 17% |
| United Kingdom | 2 | 17% |
| Germany | 1 | 8% |
| Canada | 1 | 8% |
| Côte d'Ivoire | 1 | 8% |
| Spain | 1 | 8% |
| Brazil | 1 | 8% |
| Unknown | 3 | 25% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 10 | 83% |
| Practitioners (doctors, other healthcare professionals) | 2 | 17% |
Mendeley readers
The data shown below were compiled from readership statistics for 210 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Ecuador | 2 | <1% |
| United Kingdom | 1 | <1% |
| Ireland | 1 | <1% |
| Canada | 1 | <1% |
| Unknown | 205 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 35 | 17% |
| Researcher | 24 | 11% |
| Student > Bachelor | 24 | 11% |
| Student > Ph. D. Student | 19 | 9% |
| Other | 13 | 6% |
| Other | 33 | 16% |
| Unknown | 62 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 86 | 41% |
| Nursing and Health Professions | 20 | 10% |
| Agricultural and Biological Sciences | 12 | 6% |
| Biochemistry, Genetics and Molecular Biology | 9 | 4% |
| Psychology | 5 | 2% |
| Other | 20 | 10% |
| Unknown | 58 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 February 2016.
All research outputs
#3,088,372
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#5,734
of 11,499 outputs
Outputs of similar age
#19,589
of 178,136 outputs
Outputs of similar age from Cochrane database of systematic reviews
#78
of 178 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one has gotten more attention than average, scoring higher than 52% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 178,136 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 178 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.